Literature DB >> 24679467

Innate lymphoid cells and asthma.

Sanhong Yu1, Hye Young Kim2, Ya-Jen Chang3, Rosemarie H DeKruyff1, Dale T Umetsu4.   

Abstract

Asthma is a complex and heterogeneous disease with several phenotypes, including an allergic asthma phenotype characterized by TH2 cytokine production and associated with allergen sensitization and adaptive immunity. Asthma also includes nonallergic asthma phenotypes, such as asthma associated with exposure to air pollution, infection, or obesity, that require innate rather than adaptive immunity. These innate pathways that lead to asthma involve macrophages, neutrophils, natural killer T cells, and innate lymphoid cells, newly described cell types that produce a variety of cytokines, including IL-5 and IL-13. We review the recent data regarding innate lymphoid cells and their role in asthma.
Copyright © 2014 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  Airway hyperreactivity; allergy; asthma; influenza; innate lymphoid cells; natural killer T cells

Mesh:

Year:  2014        PMID: 24679467     DOI: 10.1016/j.jaci.2014.02.015

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  35 in total

Review 1.  Take the Wnt out of the inflammatory sails: modulatory effects of Wnt in airway diseases.

Authors:  Sebastian Reuter; Hendrik Beckert; Christian Taube
Journal:  Lab Invest       Date:  2015-11-23       Impact factor: 5.662

2.  Allergies and Disease Severity in Childhood Narcolepsy: Preliminary Findings.

Authors:  Secil Aydinoz; Yu-Shu Huang; David Gozal; Clara O Inocente; Patricia Franco; Leila Kheirandish-Gozal
Journal:  Sleep       Date:  2015-12-01       Impact factor: 5.849

3.  Priming with high and low respiratory allergen dose induces differential CD4+ T helper type 2 cells and IgE/IgG1 antibody responses in mice.

Authors:  Kazuki Furuhashi; Yen L Chua; Kenneth H S Wong; Qian Zhou; Debbie C P Lee; Ka H Liong; Guo H Teo; Paul E Hutchinson; David M Kemeny
Journal:  Immunology       Date:  2017-04-03       Impact factor: 7.397

Review 4.  Biologic therapies targeting eosinophils: current status and future prospects.

Authors:  Fanny Legrand; Amy D Klion
Journal:  J Allergy Clin Immunol Pract       Date:  2015 Mar-Apr

5.  ILC2: There's a New Cell in Town.

Authors:  Yuan Min Wang; Mahnoor Bakhtiar; Stephen I Alexander
Journal:  J Am Soc Nephrol       Date:  2017-05-31       Impact factor: 10.121

Review 6.  Respiratory viral infection, epithelial cytokines, and innate lymphoid cells in asthma exacerbations.

Authors:  Rakesh K Kumar; Paul S Foster; Helene F Rosenberg
Journal:  J Leukoc Biol       Date:  2014-06-05       Impact factor: 4.962

Review 7.  Immunopathology alters Th17 cell glucocorticoid sensitivity.

Authors:  J Banuelos; Y Cao; S C Shin; N Z Lu
Journal:  Allergy       Date:  2016-10-13       Impact factor: 13.146

8.  Understanding allergic multimorbidity within the non-eosinophilic interactome.

Authors:  Daniel Aguilar; Nathanael Lemonnier; Gerard H Koppelman; Erik Melén; Baldo Oliva; Mariona Pinart; Stefano Guerra; Jean Bousquet; Josep M Anto
Journal:  PLoS One       Date:  2019-11-06       Impact factor: 3.240

Review 9.  The microbiome-metabolome crosstalk in the pathogenesis of respiratory fungal diseases.

Authors:  Samuel M Gonçalves; Katrien Lagrou; Cláudio Duarte-Oliveira; Johan A Maertens; Cristina Cunha; Agostinho Carvalho
Journal:  Virulence       Date:  2016-11-07       Impact factor: 5.882

10.  Concomitant suppression of TH2 and TH17 cell responses in allergic asthma by targeting retinoic acid receptor-related orphan receptor γt.

Authors:  Hyeongjin Na; Hoyong Lim; Garam Choi; Byung-Keun Kim; Sae-Hoon Kim; Yoon-Seok Chang; Roza Nurieva; Chen Dong; Seon Hee Chang; Yeonseok Chung
Journal:  J Allergy Clin Immunol       Date:  2017-09-22       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.